The World Orphan Drug Congress USA 2025 is dedicated to the opportunities and challenges for commercialization and market potential for drugs to treat rare diseases.
The World Orphan Drug Congress USA 2025 covers topics such as:
- Global trends in orphan drug development
- Biotech commercial strategies
- Big Pharma strategies
- Clinical development strategies
- Patient partnerships
- Funding orphan drug R&D
- Expanding product indications
- Making patients the priority
The World Orphan Drug Congress USA 2025 is a conference that brings together:
- Pharmaceutical companies
- Biotech companies
- Academic and research institutions
- Government agencies
- CROs
- CMOs
- Law firms
- Consultants
- Equipment and technology providers
- Venture capital and private equity
